By Stephen Nakrosis
Shares of LifeMD were trading in the green in the after-hours session following the release of fourth-quarter financial results that topped some analysts' estimates and the release of 2025 guidance.
After the bell, the company's shares were trading 24% higher, at $5.31. The stock ended Monday's regular session with an 8.5% loss, closing at $4.27.
LifeMD reported a fourth-quarter loss per share of 2 cents. Analysts were expecting a loss of 5 cents per share, according to FactSet. Revenue for the fourth quarter came in at $64.3 million. Analysts had expected revenue of $57.5 million, according to FactSet.
On an adjusted basis, LifeMD reported fourth-quarter earnings per share of 21 cents.
For full year 2024, the telehealth company reported revenue of $212.5 million. LifeMD said it was expecting 2025 revenue in a range of $265 million to $275 million, and first-quarter revenue of $61 million to $63 million.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 10, 2025 17:37 ET (21:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.